Necla Kulabaş

Synthesis and antiproliferative evaluation of novel 2-(4H-1,2,4-triazole-3-ylthio)acetamide derivatives as inducers of apoptosis in cancer cells

Necla Kulabaş, Esra Tatar, Özlem Bingöl Özakpınar et al. · European Journal of Medicinal Chemistry · 2016 · 101 citations

Life Sciences, Medicinal Chemistry, Pharmacology +14

Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors

Sevil Şenkardeş, M. İhsan Han, Necla Kulabaş et al. · Molecular Diversity · 2019 · 67 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents

Aslı Türe, Necla Kulabaş, Serap İpek Dingiş-Birgül et al. · Bioorganic Chemistry · 2019 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Novel fluoroquinolones containing 2‐arylamino‐2‐oxoethyl fragment: Design, synthesis, evaluation of antibacterial and antituberculosis activities and molecular modeling studies

Necla Kulabaş, Aslı Türe, Arif Bozdeveci et al. · Journal of Heterocyclic Chemistry · 2021 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

One‐pot, Four‐Component Green Synthesis, Carbonic Anhydrase II Inhibition and Docking Studies of 5‐Arylidenerhodanines

Arif Mermer, Neslihan Demirbaş, Ahmet Çolak et al. · ChemistrySelect · 2018 · 17 citations

Natural Sciences, Chemistry, Medicinal Chemistry +15